HEALTH TECHNOLOGY ASSESSMENT: CONITEC REPORTS BETWEEN 2023 AND 2025

Abstract

One of the policies for promoting public health is the incorporation of technologies into the Unified Health System (SUS), which occurs through the Health Technology Assessment (HTA) procedure carried out by the National Commission for the Incorporation of Technology in the Health System (Conitec). It is the HTA report that forms the basis for the opinion on whether or not to incorporate technologies and which, in turn, will underpin the Ministry of Health's decision on the matter. In this respect, Conitec's mission is to evaluate the efficacy and safety of these technologies. However, economic patterns are observed in these analyses, even though there are no absolute values ​​to define how much public resources can be employed in each technology. On the other hand, the pharmaceutical industry launches products with greater precision in targeting pathologies and at a higher acquisition cost. In this sense, a survey was conducted to determine how many technologies evaluated by Conitec, between 2023 and 2025, received a conclusion against incorporation and what the reasons were. The results were as follows: 241 technologies evaluated, 51 results for non-incorporation: 3% because another technology is available in the SUS (Brazilian Public Health System), 62% due to high economic impact, 15% due to lack of scientific evidence, and 17% due to lack of evidence and high economic impact. It was also analyzed that in 68% of cases there is no substitute for the technology in the SUS, 47% of the non-incorporations due to lack of scientific evidence do not align with the searches in the AI ​​tool: Consensus, and 91,8% of the negative recommendations are positively recommended in England.